KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$1.4 billion.

  • Twist Bioscience's Retained Earnings fell 601.48% to -$1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.4 billion, marking a year-over-year decrease of 601.48%. This contributed to the annual value of -$1.3 billion for FY2025, which is 625.41% down from last year.
  • As of Q4 2025, Twist Bioscience's Retained Earnings stood at -$1.4 billion, which was down 601.48% from -$1.3 billion recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Retained Earnings peaked at -$529.3 million during Q1 2021, and registered a low of -$1.4 billion during Q4 2025.
  • In the last 5 years, Twist Bioscience's Retained Earnings had a median value of -$1.0 billion in 2023 and averaged -$985.1 million.
  • As far as peak fluctuations go, Twist Bioscience's Retained Earnings plummeted by 3653.36% in 2022, and later tumbled by 601.48% in 2025.
  • Twist Bioscience's Retained Earnings (Quarter) stood at -$656.1 million in 2021, then tumbled by 32.64% to -$870.2 million in 2022, then decreased by 23.67% to -$1.1 billion in 2023, then decreased by 18.33% to -$1.3 billion in 2024, then fell by 6.01% to -$1.4 billion in 2025.
  • Its last three reported values are -$1.4 billion in Q4 2025, -$1.3 billion for Q3 2025, and -$1.3 billion during Q2 2025.